Nchi: Singapoo
Lugha: Kiingereza
Chanzo: HSA (Health Sciences Authority)
Meloxicam
EURO ASIA MEDICO PTE. LTD.
M01AC06
7.50mg
TABLET, ORALLY DISINTEGRATING
ORAL
Prescription Only
Alpex Pharma SA
2012-10-15
NULOX ® 7.5 NULOX ® 15 MELOXICAM ORODISPERSIBLE TABLET PRESENTATION Nulox ® 7.5 contains meloxicam 7.5 mg per tablet and are light yellow, flat, and embossed with AX6 on one side. Nulox ® 15 contains meloxicam 15 mg per tablet and are light yellow, flat, scored and embossed with AX5 on one side. The other ingredients are mannitol (E421), aspartame (E951), sorbitol (E420), citric acid anhydrous (E330), yoghurt flavour, forest fruit flavour, povidone (E1201), talc (E553b), sodium lauryl sulfate and magnesium stearate (E572). PHARMACODYNAMIC PROPERTIES ATC code: M01AC06 Nulox ® is a non-steroidal anti-inflammatory drug (NSAID) of the enolic acid class, which has shown anti-inflammatory, analgesic and antipyretic properties in animals. Meloxicam showed potent anti- inflammatory activity in all standard models of inflammation. A common mechanism for the above effects may exist in the ability of meloxicam to inhibit the biosynthesis of prostaglandins, known mediators of inflammation. Comparison of the ulcerogenic dose and the anti-inflammatory effective dose in the rat adjuvant arthritis model confirmed a superior therapeutic margin in animals over standard NSAIDs. In vivo, meloxicam inhibited prostaglandin biosynthesis more potently at the site of inflammation than in the gastric mucosa or the kidney. These differences are thought to be related to a selective inhibition of COX-2 relative to COX-1 and it is believed that COX-2 inhibition provides the therapeutic effects of NSAIDs whereas inhibit Soma hati kamili